On the other hand, CRC risk loci identified by genome-wide association studies (GWAS) include several variants that regulate the expression of TGF-β/BMP signaling components such as GREM1, BMP2, BMP4, SMAD7, and SMAD9 [25, 26]. This evidence concerns the gene GREM1 and colorectal carcinoma.